DOI: 10.1128/AAC.44.10.2638-2644.2000
Article Information
PubMed
Published By
History
- Received January 24, 2000
- Returned for modification April 13, 2000
- Accepted June 28, 2000
- Published online October 1, 2000.
Copyright & Usage
Copyright © 2000 American Society for Microbiology
Author Information
- Yae Kurosawa1,2,
- Arnulf Dorn3*,
- Michiko Kitsuji-Shirane1,4,
- Hisao Shimada1,
- Tomoko Satoh1,5,
- Hugues Matile3,
- Werner Hofheinz3,
- Raffaello Masciadri3,
- Manfred Kansy3 and
- Robert G. Ridley3,6
- Department of Pharmaceutical Screening, Nippon Roche Research Center, 200 Kajiwara, Kamakura, Kanagawa Prefecture 247,1
- New Ceramics Department, Asahi Optical Co., Ltd., Itabashi-ku, Tokyo 174-8639,2
- Medical Institute of Bioregulation, Department of Molecular and Cellular Biology, Kyushu University, 3-1-1 Maidaishi, Higashi-ku Fukuoka, Fukuoka 812-8582,4 and
- Screening Technology, Bayer Yakuhin Research Center Kyoto, 6-5-1-3 Kunimidai, Soraku-gun, Kyoto,5 Japan, and
- Pharma Division, Preclinical Research, F. Hoffmann-La Roche Ltd., CH-4070 Basel,3 and
- Drug Discovery Research, WHO/TDR, World Health Organization, CH-1211 Geneva 27,6 Switzerland
↵* Corresponding author. Mailing address: F. Hoffmann-La Roche Ltd, PRPI-D, Building 70/138, CH-4070 Basel, Switzerland. Phone: (61) 688 84 11. Fax: (61) 688 27 29. E-mail:arnulf.dorn{at}roche.com.